Listed

Arcus Biosciences, Inc.

RCUSNYSECIK 1724521HealthcareFiscal year ends Dec 31

Reports and events: 148 filings

Newest first, by EDGAR acceptance time (Eastern). Each filing’s page lists its documents on sec.gov and, for 10-K and 10-Q reports, the extracted sections.

What the forms are: 10-K, 10-Q, 8-K, Form 4, DEF 14A, Schedule 13D, Schedule 13G, amendments, accession numbers.

Arcus Biosciences, Inc., Reports and events
FiledFormWhat it isAccession number
2024-01-3008:17 ET8-K1.01 Entry into a material agreement; 3.02 Unregistered sale of equity; 5.02 Departure or appointment of officers or directors; 8.01 Other events; 9.01 Financial statements and exhibits0001724521-24-000034
2023-11-0716:11 ET10-QQuarterly reportPeriod 2023-09-300001724521-23-000021
2023-11-0716:04 ET8-K2.02 Results of operations; 9.01 Financial statements and exhibits0001724521-23-000018
2023-08-0708:13 ET10-QQuarterly reportPeriod 2023-06-300000950170-23-038760
2023-08-0708:08 ET8-K2.02 Results of operations; 9.01 Financial statements and exhibits0000950170-23-038757
2023-06-2808:25 ET8-K1.01 Entry into a material agreement; 3.02 Unregistered sale of equity0000950170-23-030273
2023-06-1616:19 ET8-K5.07 Shareholder vote results; 8.01 Other events; 9.01 Financial statements and exhibits0000950170-23-028621
2023-06-0508:25 ET8-K7.01 Regulation FD disclosure; 8.01 Other events0000950170-23-026241
2023-05-1508:34 ET8-K1.01 Entry into a material agreement0000950170-23-021988
2023-05-0916:15 ET10-QQuarterly reportPeriod 2023-03-310000950170-23-019695
2023-05-0916:10 ET8-K2.02 Results of operations; 9.01 Financial statements and exhibits0000950170-23-019659
2023-04-2116:09 ETDEF 14AProxy statement0000950170-23-013840
2023-03-1016:46 ET8-K5.02 Departure or appointment of officers or directors0000950170-23-007320
2023-02-2816:18 ET10-KAnnual reportPeriod 2022-12-310000950170-23-005112
2023-02-2816:11 ET8-K2.02 Results of operations; 9.01 Financial statements and exhibits0000950170-23-005084
2022-12-1917:05 ET8-K8.01 Other events0000950170-22-026760
2022-11-2808:39 ET8-K8.01 Other events0000950170-22-025712
2022-11-0216:11 ET10-QQuarterly reportPeriod 2022-09-300000950170-22-021241
2022-11-0216:05 ET8-K2.02 Results of operations; 9.01 Financial statements and exhibits0000950170-22-021219
2022-10-1116:13 ET8-K1.01 Entry into a material agreement; 9.01 Financial statements and exhibits0001193125-22-260620
2022-08-0316:22 ET10-QQuarterly reportPeriod 2022-06-300000950170-22-014280
2022-08-0316:16 ET8-K2.02 Results of operations; 9.01 Financial statements and exhibits0000950170-22-014263
2022-06-1616:14 ET8-K5.07 Shareholder vote results; 8.01 Other events; 9.01 Financial statements and exhibits0000950170-22-011747
2022-05-0916:15 ET10-QQuarterly reportPeriod 2022-03-310000950170-22-008502
2022-05-0916:08 ET8-K2.02 Results of operations; 9.01 Financial statements and exhibits0000950170-22-008484
2022-04-2016:12 ETDEF 14AProxy statementPeriod 2022-06-140000950170-22-005855
2022-02-2316:16 ET10-KAnnual reportPeriod 2021-12-310000950170-22-001788
2022-02-2316:08 ET8-K2.02 Results of operations; 9.01 Financial statements and exhibits0000950170-22-001777
2021-12-2116:40 ET8-K8.01 Other events0000950170-21-005305
2021-11-1807:06 ET8-K1.01 Entry into a material agreement0000950170-21-004749
2021-11-0817:11 ET8-K2.02 Results of operations; 9.01 Financial statements and exhibits0000950170-21-003506
2021-11-0816:16 ET10-QQuarterly reportPeriod 2021-09-300000950170-21-003471
2021-08-1116:33 ET8-K5.02 Departure or appointment of officers or directors0001564590-21-043472
2021-08-0516:19 ET10-QQuarterly reportPeriod 2021-06-300001564590-21-041611
2021-08-0516:13 ET8-K2.02 Results of operations; 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits0001564590-21-041591
2021-07-1916:47 ET8-K5.02 Departure or appointment of officers or directors; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits0001564590-21-037042
2021-06-0716:26 ET8-K5.07 Shareholder vote results; 8.01 Other events; 9.01 Financial statements and exhibits0001564590-21-031965
2021-05-0516:19 ET10-QQuarterly reportPeriod 2021-03-310001564590-21-024084
2021-05-0516:13 ET8-K2.02 Results of operations; 9.01 Financial statements and exhibits0001564590-21-024065
2021-04-2616:24 ET8-K7.01 Regulation FD disclosure0001564590-21-020541
2021-04-2016:09 ETDEF 14AProxy statementPeriod 2021-06-030001564590-21-019630
2021-04-1919:02 ET8-K3.01 Delisting notice0001564590-21-019230
2021-03-1616:06 ET8-K8.01 Other events0001564590-21-013565
2021-02-2519:10 ET10-KAnnual reportPeriod 2020-12-310001564590-21-008270
2021-02-2416:13 ET8-K2.02 Results of operations; 9.01 Financial statements and exhibits0001564590-21-008094
2021-02-0108:08 ET8-K1.01 Entry into a material agreement; 3.02 Unregistered sale of equity0001564590-21-003492
2021-01-0616:15 ET8-K5.02 Departure or appointment of officers or directors0001564590-21-000408
2020-12-1816:13 ET8-K5.02 Departure or appointment of officers or directors; 7.01 Regulation FD disclosure0001564590-20-057677
2020-11-0516:25 ET10-QQuarterly reportPeriod 2020-09-300001564590-20-051355
2020-11-0516:16 ET8-K2.02 Results of operations; 9.01 Financial statements and exhibits0001564590-20-051327

Source: SEC EDGAR, the company’s filing index. Last ingested by Listed: Nov 4, 2026, 17:06 ET. Listed shows no prices and gives no investment advice.